KLRC2 and lymphoma: In the present study, we hypothesized that a potent EBV LMP-1-mediated inhibition of NKG2A+ and an absent activation of pro-inflammatory NKG2C+ NK cells contribute to the immune evasion of EBV-infected cells and the development of EBV-associated lymphomas.